Evidence map›Paper›PMID 41816546›Full record

ArticleSurgical case reports2026

Complete Resection of a Giant Hypervascular Pelvic Floor Solitary Fibrous Tumor Using Intraoperative Balloon Occlusion and Staged Open Abdomen Management: A Case Report.

Masahiro Hashimoto, Taishi Hata, Hiroki Akashi, Shinya Kato, Yoshihiro Morimoto, Yujiro Nishizawa, Kenta Furukawa, Miho Yamakawa, Tetsuro Nakazawa, Keiko Matsuoka and 4 more

Abstract readCase Reports
In one paragraph

Article in Surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Masahiro HashimotoDepartment of Gastroenterological Surgery, Osaka General Medical Center, Osaka, Osaka, Japan.
Taishi HataDepartment of Gastroenterological Surgery, Osaka General Medical Center, Osaka, Osaka, Japan.
Hiroki AkashiDepartment of Gastroenterological Surgery, Osaka General Medical Center, Osaka, Osaka, Japan.
Shinya KatoDepartment of Gastroenterological Surgery, Osaka General Medical Center, Osaka, Osaka, Japan.
Yoshihiro MorimotoDepartment of Gastroenterological Surgery, Osaka General Medical Center, Osaka, Osaka, Japan.
Yujiro NishizawaDepartment of Gastroenterological Surgery, Osaka General Medical Center, Osaka, Osaka, Japan.
Kenta FurukawaDepartment of Gastroenterological Surgery, Osaka General Medical Center, Osaka, Osaka, Japan.
Miho YamakawaDepartment of Diagnostic and Interventional Radiology, Osaka General Medical Center, Osaka, Osaka, Japan.
Tetsuro NakazawaDepartment of Diagnostic and Interventional Radiology, Osaka General Medical Center, Osaka, Osaka, Japan.
Keiko MatsuokaDepartment of Pathology, Osaka General Medical Center, Osaka, Osaka, Japan.
Kohki ShimazuDepartment of Pathology, Osaka General Medical Center, Osaka, Osaka, Japan.
Akira TomokuniDepartment of Gastroenterological Surgery, Osaka General Medical Center, Osaka, Osaka, Japan.
Masaaki MotooriDepartment of Gastroenterological Surgery, Osaka General Medical Center, Osaka, Osaka, Japan.
Kazumasa FujitaniDepartment of Gastroenterological Surgery, Osaka General Medical Center, Osaka, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSolitary fibrous tumors (SFTs) are rare fibroblastic neoplasms that can occur at various anatomical sites, including the pleura, retroperitoneum, and pelvis. Although surgical resection remains the mainstay of curative treatment, pelvic SFTs often present as giant hypervascular tumors, making intraoperative bleeding control particularly challenging. CASE PRESENTATION: A 66-year-old man presented with progressive abdominal distension, constipation, and dysuria. CT revealed a large pelvic mass measuring 200 × 176 × 140 mm, with multiple intratumoral vessels and areas of necrosis accompanied by bilateral hydronephrosis. MRI revealed a heterogeneously hyperintense signal on T2-weighted images. Preoperative angiography revealed multiple feeding arteries from the bilateral internal iliac, inferior mesenteric, and median sacral arteries. Preoperative embolization was deemed technically difficult because of the extensive vascular network. Intraoperative balloon occlusion catheters were therefore placed in both internal iliac arteries to control pelvic blood flow. The tumor was resected via open surgery, along with partial cystectomy and ureteral resection, followed by reconstruction. Persistent venous oozing required temporary open abdomen management using Abthera, and definitive closure was achieved the following day after confirmation of hemostasis and application of Surgiflo. The resected specimen measured 210 × 200 × 140 mm and weighed 2865 g. Histologically, the tumor consisted of spindle cells with low mitotic activity. Immunohistochemistry revealed positivity for signal transducer and activator of transcription 6 (STAT6) and negativity for cluster of differentiation 34 (CD34), confirming the diagnosis of SFT. The postoperative course was complicated by pulmonary embolism, which was successfully managed with anticoagulation therapy. The patient remains disease-free 1 month after surgery.

conclusionsThis case of a giant pelvic floor SFT with CD34 negativity and STAT6 positivity demonstrates that intraoperative balloon occlusion and staged open abdominal management can be effective strategies for controlling intraoperative bleeding in hypervascular pelvic tumors. Individualized planning and staged approaches are crucial for facilitating tumor resection in such highly challenging cases.

Indexed as

balloon occlusioninternal iliac vesselsopen abdomen managementpelvic floorsolitary fibrous tumor

Identifiers

PMID41816546
PMCPMC12972382

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.